Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Harro

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Brain Research|April 20, 2001
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistryJ Harro, M Tõnissaar, M Eller, et al.
Neuropharmacology|June 1, 1994
Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-mazeE Vasar, A Lang, J Harro, et al.
Psychopharmacology|January 1, 1991
Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouseE Vasar, J Harro, A Lang, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 8, 2010
Environment and the serotonergic systemL Oreland, N Nordquist, J Hallman, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1997
Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized ratsA Kask, J Harro, P Tuomaine, et al.
Scandinavian Journal of Medicine & Science in Sports|November 3, 2017
Low fitness is associated with metabolic risk independently of central adiposity in a cohort of 18-year-oldsE Lätt, J Jürimäe, J Harro, et al.
Pharmacology & Toxicology|January 1, 1990
Stress-protection action of beta-phenyl(GABA): involvement of central and peripheral type benzodiazepine binding sitesL Rägo, R A Kiivet, A Adojaan, et al.
Psychopharmacology|January 1, 1993
Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-mazeE Vasar, E Peuranen, T Oöpik, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2000
Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenicsJ A Prince, J Harro, K Blennow, et al.
Neuroscience|April 29, 2005
Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activityA Alttoa, K Kõiv, M Eller, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Brain Research|April 20, 2001
Chronic variable stress and partial 5-HT denervation by parachloroamphetamine treatment in the rat: effects on behavior and monoamine neurochemistryJ Harro, M Tõnissaar, M Eller, et al.
Neuropharmacology|June 1, 1994
Evidence for potentiation by CCK antagonists of the effect of cholecystokinin octapeptide in the elevated plus-mazeE Vasar, A Lang, J Harro, et al.
Psychopharmacology|January 1, 1991
Differential involvement of CCK-A and CCK-B receptors in the regulation of locomotor activity in the mouseE Vasar, J Harro, A Lang, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|May 8, 2010
Environment and the serotonergic systemL Oreland, N Nordquist, J Hallman, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|February 1, 1997
Overflow of noradrenaline and dopamine in frontal cortex after [N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine] (DSP-4) treatment: in vivo microdialysis study in anaesthetized ratsA Kask, J Harro, P Tuomaine, et al.
Scandinavian Journal of Medicine & Science in Sports|November 3, 2017
Low fitness is associated with metabolic risk independently of central adiposity in a cohort of 18-year-oldsE Lätt, J Jürimäe, J Harro, et al.
Pharmacology & Toxicology|January 1, 1990
Stress-protection action of beta-phenyl(GABA): involvement of central and peripheral type benzodiazepine binding sitesL Rägo, R A Kiivet, A Adojaan, et al.
Psychopharmacology|January 1, 1993
Ondansetron, an antagonist of 5-HT3 receptors, antagonizes the anti-exploratory effect of caerulein, an agonist of CCK receptors, in the elevated plus-mazeE Vasar, E Peuranen, T Oöpik, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|February 29, 2000
Putamen mitochondrial energy metabolism is highly correlated to emotional and intellectual impairment in schizophrenicsJ A Prince, J Harro, K Blennow, et al.
Neuroscience|April 29, 2005
Effects of low dose N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine administration on exploratory and amphetamine-induced behavior and dopamine D2 receptor function in rats with high or low exploratory activityA Alttoa, K Kõiv, M Eller, et al.
Pageof 8